Ibrutinib

Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.

Price Not Available 200 mg Ibrutinib Supplier Page

Catalog Number	T1835
Alternative Name(s)	PCI-32765
Research Area	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|PROTAC
Molecular Formula	C25H24N6O2
CAS#	936563-96-1
Purity	99.79%
SMILES	Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C
Size	200 mg
Supplier Page	https://www.targetmol.com/compound/Ibrutinib
Additional Information	https://www.targetmol.com/datasheet/T1835